The Detection and Clinical Significance of Anti-SLA/LP, LKM-1 and GP210 Antibodies in Patients with Autoimmune Liver Disease

The Detection and Clinical Significance of Anti-SLA/LP, LKM-1 and GP210 Antibodies in Patients with Autoimmune Liver Disease

GUI Tiejun, CHEN Congzhe, CUI Huimin, LI Xueke

PDF(983 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(983 KB)

Labeled Immunoassays and Clinical Medicine ›› 2024, Vol. 31 ›› Issue (12) : 2266-2270. DOI: 10.11748/bjmy.issn.1006-1703.2024.12.016

Clinical Investigation

The Detection and Clinical Significance of Anti-SLA/LP, LKM-1 and GP210 Antibodies in Patients with Autoimmune Liver Disease

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 31(12): 2266-2270 https://doi.org/10.11748/bjmy.issn.1006-1703.2024.12.016

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(983 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉